Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 199.95
-0.55 (-0.27%)
At close: Jan 22, 2026
Hikal Market Cap
Hikal has a market cap or net worth of 23.92 billion as of January 23, 2026. Its market cap has decreased by -51.23% in one year.
Market Cap
23.92B
Enterprise Value
30.56B
Revenue
16.99B
Ranking
n/a
PE Ratio
236.90
Stock Price
199.95
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 23.92B, an increase of 1,662.47%. That is a compound annual growth rate of 12.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 24.65B | -11.88% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 62.32B |
| Gufic Biosciences | 31.41B |
| Unichem Laboratories | 28.08B |
| Shukra Pharmaceuticals | 22.26B |
| Morepen Laboratories | 20.24B |
| Novartis India | 19.27B |
| Amrutanjan Health Care | 17.64B |
| Bliss GVS Pharma | 16.61B |